Stockreport

Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar [BNN Bloomberg (Canada)]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Adjusted earnings for the year will be $8.53 to $8.65 a share, the company said in a statement, up from the $8.44 to $8.59 guidance it gave in February. Keytruda sales [Read more]